Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 5;83(19):3558-3573.e7.
doi: 10.1016/j.molcel.2023.09.006.

A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells

Affiliations
Free article

A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells

Sophia Magkouta et al. Mol Cell. .
Free article

Abstract

Cellular senescence is a stress-response mechanism implicated in various physiological processes, diseases, and aging. Current detection approaches have partially addressed the issue of senescent cell identification in clinical specimens. Effective methodologies enabling precise isolation or live tracking of senescent cells are still lacking. In-depth analysis of truly senescent cells is, therefore, an extremely challenging task. We report (1) the synthesis and validation of a fluorophore-conjugated, Sudan Black-B analog (GLF16), suitable for in vivo and in vitro analysis of senescence by fluorescence microscopy and flow cytometry and (2) the development and application of a GLF16-carrying micelle vector facilitating GLF16 uptake by living senescent cells in vivo and in vitro. The compound and the applied methodology render isolation of senescent cells an easy, rapid, and precise process. Straightforward nanocarrier-mediated GLF16 delivery in live senescent cells comprises a unique tool for characterization of senescence at an unprecedented depth.

Keywords: GLF-16; flow cytometry; fluorescence microscopy; live tracking; micelle; optimized SBB analogs; senescence.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Pending patents: (1) Greek Patent Application 20230100019 and (2) University of Dundee 20230100019, regarding SBB analogs hydrophilic compounds on chemical synthesis, method(s), and application(s) use. M.S. is shareholder of Altos Labs, Senolytic Therapeutics, Life Biosciences, and Rejuveron Senescence Therapeutics, and was consultant, until the end of 2022, for Altos Labs and Rejuveron Senescence Therapeutics.

Publication types

Substances

LinkOut - more resources